This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

24-26 Feb, 2026

Grand Nikko Tokyo DaibaTokyo

Dr. Steven Fakharzadeh, MD, PhD
Johnson & Johnson における Global Medical Affairs Leader Immunodermatology
スピーカー

アジェンダセッション

Program Update on Icotrokinra (JNJ-2113) in Psoriasis: The First-in-Class Investigational Targeted Oral Peptide Designed to Block the IL-23 Receptor
28 2月, 1:45pm
セッションを見る

このイベントで

前へ

次へ

Dr. Xinxin Gao, PhD

Principal Scientific Manager, Peptide Therapeutics